Skip to content

Plasma Extracellular Vesicle Omics Biomarkers Associated with the Time-Dependent Effects of Electroconvulsive Therapy in Schizophrenia

Plasma Extracellular Vesicle Omics Biomarkers Associated with the Time-Dependent Effects of Electroconvulsive Therapy in Schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100881
Enrollment
Unknown
Registered
2025-04-16
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Schizophrenia group:None

Sponsors

The Affiliated Brain Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis meets the criteria for schizophrenia according to DSM-V; 2. Age between 18 and 65 years, and patients with schizophrenia who are about to undergo electroconvulsive therapy (ECT); 3. Patients and their families voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of other psychiatric or neurological disorders, or severe physical illnesses; 2. Received electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) within six months prior to enrollment; 3. Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Positive and Negative Symptom Scale;Minimum Mental State Examination;Positive and Negative Symptom Scale;Minimum Mental State Examination;

Countries

China

Contacts

Public ContactPeijuan Wang

Nantong Fourth People's Hospital

821423120@qq.com+86 513 8560 6903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026